Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Structural insight into receptor-selectivity for lurasidone.
Ichikawa O, Okazaki K, Nakahira H, Maruyama M, Nagata R, Tokuda K, Horisawa T, Yamazaki K. Ichikawa O, et al. Among authors: horisawa t. Neurochem Int. 2012 Dec;61(7):1133-43. doi: 10.1016/j.neuint.2012.08.005. Epub 2012 Aug 21. Neurochem Int. 2012. PMID: 22929996
Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity.
Ishibashi T, Horisawa T, Tokuda K, Ishiyama T, Ogasa M, Tagashira R, Matsumoto K, Nishikawa H, Ueda Y, Toma S, Oki H, Tanno N, Saji I, Ito A, Ohno Y, Nakamura M. Ishibashi T, et al. Among authors: horisawa t. J Pharmacol Exp Ther. 2010 Jul;334(1):171-81. doi: 10.1124/jpet.110.167346. Epub 2010 Apr 19. J Pharmacol Exp Ther. 2010. PMID: 20404009
The effects of selective antagonists of serotonin 5-HT7 and 5-HT1A receptors on MK-801-induced impairment of learning and memory in the passive avoidance and Morris water maze tests in rats: mechanistic implications for the beneficial effects of the novel atypical antipsychotic lurasidone.
Horisawa T, Ishibashi T, Nishikawa H, Enomoto T, Toma S, Ishiyama T, Taiji M. Horisawa T, et al. Behav Brain Res. 2011 Jun 20;220(1):83-90. doi: 10.1016/j.bbr.2011.01.034. Epub 2011 Jan 26. Behav Brain Res. 2011. PMID: 21277905
Evaluation of dopamine D₂/D₃ and serotonin 5-HT₂A receptor occupancy for a novel antipsychotic, lurasidone, in conscious common marmosets using small-animal positron emission tomography.
Nakazawa S, Yokoyama C, Nishimura N, Horisawa T, Kawasaki A, Mizuma H, Doi H, Onoe H. Nakazawa S, et al. Among authors: horisawa t. Psychopharmacology (Berl). 2013 Jan;225(2):329-39. doi: 10.1007/s00213-012-2815-9. Epub 2012 Aug 7. Psychopharmacology (Berl). 2013. PMID: 22868411
Discovery of SMP-304, a novel benzylpiperidine derivative with serotonin transporter inhibitory activity and 5-HT1A weak partial agonistic activity showing the antidepressant-like effect.
Yoshinaga H, Masumoto S, Koyama K, Kinomura N, Matsumoto Y, Kato T, Baba S, Matsumoto K, Horisawa T, Oki H, Yabuuchi K, Kodo T. Yoshinaga H, et al. Among authors: horisawa t. Bioorg Med Chem. 2017 Jan 1;25(1):293-304. doi: 10.1016/j.bmc.2016.10.034. Epub 2016 Oct 29. Bioorg Med Chem. 2017. PMID: 27865645
15 results